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0022-2836 © 2010 Elsevier Ltd.Open accessIdentifying the cause of the cytotoxicity of species populated during
amyloid formation is crucial to understand the molecular basis of protein
deposition diseases. We have examined different types of aggregates
formed by lysozyme, a protein found as fibrillar deposits in patients with
familial systemic amyloidosis, by infrared spectroscopy, transmission
electron microscopy, and depolymerization experiments, and analyzed
how they affect cell viability. We have characterized two types of human
lysozyme amyloid structures formed in vitro that differ in morphology,
molecular structure, stability, and size of the cross-β core. Of particular
interest is that the fibrils with a smaller core generate a significant cytotoxic
effect. These findings indicate that protein aggregation can give rise to
species with different degree of cytotoxicity due to intrinsic differences in
their physicochemical properties.
© 2010 Elsevier Ltd.Open access under CC BY license. Introduction
Amyloid fibrils are non-covalent assemblies of
proteins that form in the tissues of patients sufferingla is to be contacted at
icine, Barcelona,
.ac.uk; xavier.
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 under CC BY license. from protein deposition diseases that include sporad-
ic and transmissible neurodegenerative disorders1,2
as well as various non-neuropathic amyloidosis.3,4 It
has been shown that non-fibrillar species transiently
populated in the early phases of in vitro aggregation of
many different proteins, including those not involved
in disease, are more cytotoxic than the corresponding
mature amyloid fibrils.5–7 This finding has led to the
suggestion that the toxicity of these species is due to
generic structural properties1,8–10 and adds to a
significant body of evidence linking the onset of
Alzheimer's and Parkinson's diseases with the
formation of similar species in the brain of patients.
Althoughnon-fibrillar oligomers are themain focus of
attention, recent studies have reported that, in some
protein systems, amyloid fibrils can also produce a
cytotoxic effect.11–13 In addition, it has been shown
that prion diseases are caused by the propagation of
infectious particles that carry all the information
Fig. 1. Amyloid morphology of lysozyme aggregates. The formation of amyloid fibrils from lysozyme at pH 7.5 (FPhys)
(a) and at pH 2.0 (FAcid) (b) was monitored by the ThT binding assay. SDS-PAGE analysis (a and b, insets) of the formed
fibrils, isolated by ultracentrifugation, confirmed that lysozyme remained intact in the fibrils. Standard molecular mass
markers are shown in lanes S, aliquots of monomeric lysozyme are shown in lanes M, and aliquots of fibrillar lysozyme,
previously dissolved in DMSO, are shown in lanes F. The TEM images of samples of FPhys (c) and FAcid (d) fibrils display,
in both cases, a fibrillar and unbranched morphology. The X-ray fiber diffraction patterns of FPhys (e) and FAcid (f) fibrils
correspond to the typical cross-β structure with meridional (white arrows) and equatorial reflections (black arrows).
784 Lysozyme Aggregates and Cytoxicity
785Lysozyme Aggregates and Cytoxicityrequired to exhibit distinct phenotypic traits in
identical hosts14 and are clearly fibrillar.15
Such observations raise the possibility that the
cytotoxicity of protein aggregates in the biological
milieu is not necessarily directly related to their
oligomeric nature but, rather, to structural properties
common to non-fibrillar and certain fibrillar aggre-
gates. In contrast to highly evolved native structures,
the structures of protein aggregates can be strongly
influenced by pH, buffer components, protein concen-
tration, and temperature;16–22 these findings have
therefore led to intense research efforts aimed at
establishing structure–activity relationships forprotein
aggregates. A particularly useful system to investigate
such relationships is lysozyme, a protein with four
disulfide bonds that is well characterized23,24 and
forms amyloid deposits in patients suffering from
familial lysozyme systemic amyloidosis,25 a disease
that occurs when amyloidogenic mutations in the
protein lead to the formation of partially unfolded
amyloidogenic intermediates.23,26,27 By incubating
lysozyme under various destabilizing conditions, we
have produced fibrils differing in morphology, molec-
ular structure, stability, and cytotoxicity. Our results
illustrate that the energy landscape of aggregation is
significantly more rugged than the folding landscape
and, importantly for understanding the molecular
basis of protein deposition disorders, that the patho-
genic properties of the aggregates formedby lysozyme
appear to be related to the fraction of sequence that is
not included in the cross-β core of the fibrils.
Results
Amyloid fibrils formed under different conditions
possess distinct cytotoxicities
Amyloid formationwas performed under strongly
destabilizing conditions, at pH 2.0, and undermilder
conditions, at pH 7.5. Since the formation of amyloid
fibrils by human lysozyme is associated with the
formation of partially folded species at the midpoint
of thermal denaturation,26 aggregation at pH 2.0was
performed at 50 °C and that at pH 7.5was performed
at 60 °C, the lowest temperatures where interme-
diates could be detected.26 Aggregation of human
lysozyme at pH 7.5 (Fig. 1a) was carried out at
60 °C, rather than at higher temperatures, to limit
degradative reactions over the timescale of the
experiment; at pH 2.0 (Fig. 1b), it was carried out at
50 °C, using seeding to eliminate the lag phase as
the reduced time required for incubation under
these conditions can prevent acid hydrolysis. The
formation of amyloid fibrils, monitored by the
thioflavin T (ThT) binding assay, took place at
pH 7.5 (Fig. 1a) and at pH 2.0 (Fig. 1b) with the
kinetics expected for non-seeded and seeded
aggregation processes, respectively.The transmission electron microscopy (TEM)
images of the material isolated by ultracentrifuga-
tion (Fig. 1c and d) showed in both cases the
presence of linear, unbranched fibrils with all the
features expected in amyloid species but with
differences in morphology. When prepared at
pH 7.5 (Fig. 1c), the fibrils presented an average
diameter of 10.7±2.8 nm and tended to associate
laterally (FPhys fibrils), whereas the fibrils formed at
pH 2.0 (Fig. 1d) presented a diameter of 6.5±0.7 nm
and were twisted (FAcid fibrils). In neither case did
the TEM images suggest the presence of non-fibrillar
aggregates, and an analysis of the length distribu-
tion of the fibrillar material formed under acid and
physiological conditions afforded no significant
differences (Fig. S1). An analysis of the aggregates
formed by human lysozyme using X-ray fiber
diffraction yielded, despite some difficulties encoun-
tered in aligning the FPhys fibrils, the two reflections
characteristic of the cross-β structure (Fig. 1e and f):
a meridional reflection at 4.8 Å and an equatorial
reflection in the vicinity of 10 Å. The former,
common to both morphologies, reports on the
distance between the β-strands in each of the sheets
of the amyloid protofilament and is a fundamental
property, observed for all fibrils characterized to
date.4,28 The latter, which reports on the spacing
between each of the sheets,28,29 differed in the two
types of fibrils: in FAcid fibrils, the reflection was at
10.4 Å (Fig. 1f), whereas FPhys fibrils showed a broad
reflection centered at 10.3 Å (Fig. 1e).
The cytotoxicity of both types of fibrilswasmeasured
by studying their effect, at total protein concentrations
ranging from 10 to 75 μM, on the viability of SH-SY5Y
neuroblastoma cells using the 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) assay.30 In
viable cells, MTT undergoes reduction by mitochon-
drial dehydrogenases (the succinate-tetrazolium re-
ductase system) to yield insoluble formazan, which
reports on the fraction of metabolically active cells.
Figure 2 shows that SH-SY5Y cells were insensitive to
native lysozyme and to FAcid fibrils. By contrast,
addition of the same quantities of the FPhys fibrils
reduced cell survival in a concentration-dependent
manner. Moreover, the A11 generic anti-oligomer
antibody developed by Kayed et al.10 did not react
with the samples in thedot blot assay (data not shown),
indicating that the cytotoxic effect described in Fig. 2
was not due to the presence of significant quantities of
the non-fibrillar oligomeric species that are recognized
by this antibody.31
The cytotoxic FPhys fibrils contain less cross-β
structure than the inert FAcid fibrils
To explain the structural origin of such differ-
ences, we analyzed the amide I region (1580–
1720 cm−1 ) of the infrared (IR) spectrum measured
using attenuated total reflectance Fourier transform
Fig. 2. Effect of addition of lysozyme fibrils on the
survival of SH-SY5Y neuroblastoma cells. SH-SY5Y cell
viability in the presence of increasing concentrations (from
10 to 75 μM) of native human lysozyme at pH 2.0 (NAcid),
FAcid fibrils, native lysozyme at pH 7.5 (NPhys), and FPhys
fibrils.
786 Lysozyme Aggregates and Cytoxicityinfrared (ATR-FTIR) spectroscopy (Fig. 3). From a
comparison of the spectra, it was evident that the
secondary structure of fibrillar lysozyme was very
different from that of the native protein and, most
importantly, that the secondary structure of the
toxic FPhys fibrils was different from that of the inert
FAcid fibrils (Fig. 3 and Table 1). The FTIR bands
obtained by deconvolution and curve fitting of the
spectra were grouped into classes corresponding
to secondary-structure elements: bands centered
between 1620 and 1640 cm−1 and between 1680
and 1700 cm−1 were assigned to β-sheet, bandsFig. 3. Structural characterization of native human lysozym
The ATR-FTIR spectra are reported as thick lines, whereas thi
by curve fitting. Among the latter, black lines are assigned to s
assigned to signals corresponding to side chains.between 1640 and 1660 cm−1 were assigned to
random/α-helix, and bands between 1660 and
1680 cm− 1 were assigned to turns/loops. The
results highlight that lysozyme undergoes pro-
found changes in conformation during fibril forma-
tion; from its largely α/β native structure (25%
β-sheet, 53% α-helix, and 22% loops and turns),
lysozyme acquired 45% of β-sheet structure in the
FPhys fibrils and 75% in the FAcid fibrils (Fig. 3 and
Table 1). FPhys fibrils contained 45% of β-sheet, 21%
of random/α-helix, and 34% of turns/loops,
whereas FAcid fibrils contained 75% of β-sheet,
15% of random/α-helix, and 10% of turns/loops.
These results clearly show that the observed
polymorphism is associated with fundamentally
different molecular conformations and, more
importantly, that the cytotoxic effect of FPhys fibrils
was related to the amount of β structure.
Since the cytotoxicity assay was performed, for the
inert FAcid fibrils, under conditions different from
those of amyloid formation, it became important to
determine whether their morphology had been
affected by the pH change and, in general, whether
the distinct morphologies interconverted upon
changing conditions. The results showed that, after
exposure to the altered pH by minimal additions of
acid or base, the morphological and structural
properties of the fibrils such as their diameter and
secondary structure, verified respectively by TEM
and FTIR, did not change significantly (Fig. 4 and
Table 2). When FPhys fibrils were incubated at
pH 2.0, the β-sheet content remained constant at
ca 45% (Fig. 4a and Table 2), the diameter of the
fibrils did not change, and an increase in the number
of individual fibrils—relative to that of the clusters
seen at physiological pH (Figs. 1c and 4c)—was
observed. FAcid fibrils exposed to physiological pHe (N) (a) and of the FPhys (b) and FAcid (c) amyloid fibrils.
n lines correspond to the individual components obtained
ignals corresponding to the main chain and gray lines are
Fig. 4. Properties of lysozyme fibrils after pH change. The pH of the solutions was changed by addition of minimal
volumes of concentrated acidic or basic solutions. After 24 h at the altered pH, FPhys (a and c) and FAcid (b and d) fibrils
were isolated by ultracentrifugation and their structure andmorphology were characterized by FTIR (a and b) and TEM (c
and d), respectively.
Table 1. Secondary-structure content of native and fibrillar human lysozyme as determined by curve fitting of the ATR-
FTIR spectra shown in Fig. 3
Assignment
N FPhys FAcid
cm−1a %b cm−1a %b cm−1a %b
β-Sheet 1620/1628 25.3±3.0 1622 67.5±5.01635 24.6±3.0 1636 6.4±2.0 1636 2.5±1.5
Random/α-helix 1653 53.0±2.0 1646 21.2±3.0 1652 14.5±0.5
Turns/loops 1677 22.4±1.5 1662 33.4±5.0 1662/1671 10.5±0.4
β-Sheet 1680 3.4±3.0 1684 0.5±0.31692 10.3±3.0 1693 4.5±0.5
a Peak position of the amide I band components, as deduced from the second-derivative spectra.
b Percentage area of the amide I band components, as obtained by integrating the area under each deconvoluted band. The error
intervals were calculated from the percentages obtained in three separate experiments; the areas corresponding to side-chain
contributions located at 1580–1610 cm−1 were not considered.
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Table 2. Secondary-structure content of lysozyme fibrils
after pH change as determined by curve fitting of ATR-
FTIR spectra shown in Fig. 4
Assignment
FPhys at pH 2.0 FAcid at pH 7.5
cm−1a %b cm−1a %b
β-Sheet 1623 34.9±5.0 1622 63.6±5.0
Random/α-helix 1642 26.8±4.0 1652 10.0±2.0
Turns/loops 1662/1672 27.5±3.0 1662/1672 18.7±1.0
β-Sheet 1687 9.0±3.0 1682 7.1±2.01702 1.8±3.0 1693 0.6±3.0
a Peak position of the amide I band components, as deduced by
the second-derivative spectra.
b Percentage area of the amide I band components, as obtained
by integrating the area under each deconvoluted band. The error
intervals were calculated from the percentages obtained in three
separate experiments; the areas corresponding to side-chain
contributions located at 1580–1610 cm−1 were not considered.
788 Lysozyme Aggregates and Cytoxicityshowed instead a slightly decreased β-sheet content
(71% instead of 75%) (Fig. 4b and Table 2), did not
show detectable changes in diameter, and had a
greater tendency to associate laterally to form
bundles than at pH 2.0 (Figs. 1d and 4d). These
changes observed in the extent of fibril association
are likely to be due to electrostatic repulsions
between individual protofilaments and fibrils due
to the fact that the charge of lysozyme at acidic and
physiological pH is +21 and +7, respectively.
Taken together, these results indicated that the pH
at which the fibrils were grown affected their nature
and morphology by modifying the conformation
that the protein adopted within the fibrils, but that
the kinetic barriers to reorganization of the fibrils
once formed were sufficiently high to limit the
effects of subsequent changes of solution conditions.
The toxic FPhys fibrils are less stable to
depolymerization than the FAcid fibrils
In order to determine whether the existence of
different morphologies with distinct degrees of
toxicity had a kinetic or a thermodynamic origin,
we assessed the stability of the fibrils by measuring
their resistance to depolymerization. The experi-
ments were carried out by incubating aliquots of
fibrils in solutions containing increasing concentra-
tions of chaotrope and then measuring the equilib-
rium concentration of soluble monomeric protein
present in the supernatant. Plots of the fraction of
soluble protein released from the amyloid fibrils at
different concentrations of chaotrope are presented
in Fig. 5. Initial studies carried out using guanidine
hydrochloride (GdnHCl) provided evidence that the
FPhys fibrils were remarkably less stable than the
FAcid fibrils; the former show a midpoint of depoly-
merization at ca 2.5MGdnHCl (Fig. 5a), whereas the
depolymerization of the latter was incomplete even
in a saturated solution of GdnHCl (Fig. 5b).To obtain comparable midpoints of depolymer-
ization, we repeated the procedure using a signifi-
cantly stronger chaotrope, guanidine thiocyanate
(GdnSCN), and the results of these experiments
yielded 0.5 and 3 M as the midpoints of
depolymerization of the FPhys and FAcid fibrils,
respectively (Fig. 5c and d). Since the stability of
fibrils has been attributed primarily to the large
number of hydrogen-bonding interactions that are
established between individual protein molecules in
the cross-β structure,32,33 these results are in
agreement with the structural characterization
carried out by IR spectroscopy, which showed that
the inert FAcid fibrils were richer in β-sheet structure
(75% β-sheet for FAcid versus 45% for FPhys) and
were therefore likely to contain significantly more
inter-strand hydrogen bonds than the toxic FPhys
fibrils.
To compare the stabilities of the two forms
under the same conditions, and taking advantage
of the fact that the fibrils did not interconvert at a
measurable rate (Fig. 4), we repeated the depoly-
merization experiments for the FPhys fibrils at
pH 2.0 and for the FAcid fibrils at pH 7.5. The
results showed that FAcid fibrils exposed to pH 7.5
were still more stable (midpoint of depolymeriza-
tion at ca 3.4 M GdnSCN) than FPhys fibrils
exposed to pH 2.0 (midpoint of depolymerization
at ca 1.8 M GdnSCN). The results (Fig. 5)
confirmed that the FPhys fibrils did not represent
the most stable configuration of the lysozyme
aggregates under a given set of conditions but
were instead trapped in a kinetically stable
configuration that contained a lower number of
stabilizing hydrogen-bonding interactions than the
FAcid fibrils.
Nature of the non-core regions of lysozyme fibrils
To gain further insight into the nature of the non-
core regions of both types of fibrils, we measured
their ability to bind 1-anilino-naphthalene-8-sulfonic
acid (ANS), a dye that displays an increase in
fluorescence emission intensity and a blue shift of its
wavelength of maximum emission upon binding
clusters of hydrophobic side chains in non-native
proteins such as molten globules.7,34–36 The results
of these experiments, presented in Fig. 6, revealed
that, under both pH conditions studied in this work
(pH 7.5 and pH 2.0), the fluorescence intensity of
ANS in the presence of the inert FAcid fibrils was
higher than that in the presence of the cytotoxic
FPhys fibrils. Given that the more stable FAcid fibrils
have a larger cross-β core than the FPhys fibrils (75%
of β structure for FAcid versus 45% for FPhys), this
result indicated that the hydrophobic side chains of
the non-core regions of the latter were, in spite of
their larger number, less accessible than those of the
non-core regions of the former, presumably due to
Fig. 5. Conformational stability of FPhys (blue) and FAcid (orange) fibrils. The stability of the fibrils was measured by
depolymerization experiments performed using GdnHCl at pH 7.5 (a) and at pH 2.0 (b) and using GdnSCN at pH 7.5 (c)
and pH 2.0 (d). Continuous lines represent the best fits to a sigmoidal function.
789Lysozyme Aggregates and Cytoxicitythe formation of local structure or to differences in
the packing of the protofilaments.
To investigate the origin of this lack of accessibility,
and by taking advantage of the presence of eight Cys
residues involved in the formation of four disulfide
bonds, we exposed preparations of both types of
fibrils to the reducing agent tris(carboxyethyl)phos-
phine (TCEP). Using Ellman's assay, we found that,
after 1 h of reaction time, ca 30–40% of the Cys
residues of both types of fibrils were reduced (Fig. 6c
and d, insets), that the fraction of reduced Cys
residues did not change significantly with time, and,
using TEM, that the morphology of the fibrils wasunaffected by the reaction (Fig. 6e and f). That both
types of fibrils show the same reactivity against
TCEP suggested that the differences in ANS binding
were due to the presence of local structure rather
than to an inability of this dye to access the non-core
regions of FPhys fibrils. This was confirmed by an
analysis of the ANS binding ability of the fibrils after
1 h in the presence of TCEP, which yielded, in
contrast with the results obtained prior to reduction,
that the fluorescence intensity of ANS was higher in
the presence of FPhys fibrils than in the presence of
FAcid fibrils (Fig. 6c and d). As expected from the
relative size of the non-core regions of these two
Fig. 6 (legend on next page)
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791Lysozyme Aggregates and Cytoxicitytypes of fibrils, these results indicated that the
partially reduced FPhys amyloid fibrils display a
larger number of clustered hydrophobic side chains
than the partially reduced FAcid fibrils and suggested
the presence of local structure, stabilized by the
native disulfide bonds of lysozyme, in the non-core
regions of the fibrils formed under physiological pH.
These results are in agreement with the recent
observation that the cytotoxicity of non-fibrillar
oligomers formed by the protein HypF-N correlates
with ANS binding.7Discussion
In contrast to globular proteins, which have
evolved to fold under physiological conditions into
a single well-defined structure, each protein se-
quence can form in vitro a wide range of distinct
aggregates depending on conditions of incubation.16
Such polymorphism affects the biological properties
of protein aggregates; in fact, small metastable
oligomers, rather than mature fibrils, are thought to
be the toxic species in neurodegenerative diseases1,5
and amyloid polymorphs are at the basis of species
barriers and strains in prion diseases.37,38 Since the
fate of the aggregation process can vary depending
on the tissue in which it occurs, on the cellular and
subcellular localization of the protein, and on
environmental conditions,18,39,40 it is important to
increase our understanding of how these species
acquire the characteristics that lead to disease.
We have found that the existence of different
morphologies in the fibrillar material formed by
human lysozyme in vitro is due to fundamental
differences in the conformation of the protein within
the amyloid structure. Toxic fibrils formed at
physiological pH (FPhys) have a lowerβ-sheet content
(Fig. 3) and are less stable to depolymerization (Fig. 5)
than those formed at acidic pH (FAcid), which are not
detactably toxic in our essay. Such polymorphism is
different from that of fibrils formed from polypep-
tides devoid of cooperatively folded structure such as
the GNNQQNY and NNQQ peptides from the yeast
prion protein Sup35,41 α-synuclein,22 and Aβ,19
where it is instead probably due to differences in
the orientation of the protofilaments and the inter-
digitation of side chains, which lead to fibrils that,
contrary towhatwehave observed, have very similar
stabilities.19 In the case of human lysozyme, it is
instead reminiscent of that displayed by the yeast
prion protein Sup35, where fibrils formed at 4 andFig. 6. ANS binding on FPhys (blue) and FAcid (orange) f
fluorescence intensity measured at 470 nm is plotted as a func
5 μM in all cases. (c and d) ANS binding on FPhys (blue) an
disulfide bonds; the concentration of ANS in these experimen
percentage of free cysteines in the fibrillar samples after reduct
fibrils, respectively, after 1 h of reduction with TCEP.37 °C presented distinct morphologies and biophy-
sical properties,37 or by the fungal prion HET-s,
where fibrils formedunder pH3.0 andpH7.0 yielded
very different NMR spectra and infectivity.42 The
polymorphism that we observed and characterized
in this work occurs at the molecular level, that is, in
the way lysozyme molecules fold in the different
amyloid states. These fundamental differences in the
properties of the protein embedded in the fibrils
can, however, have consequences with regard to
the morphology, shape and diameter, of the two
types of fibrils (Fig. 1). Variations in the number,
arrangement, and diameter of protofilaments could
in fact arise from the way the lysozyme molecules
in the fibrillar context guide the hierarchical supra-
molecular assembly of the fibrils.
Our results provide new insights into polymor-
phism by experimentally illustrating that the energy
landscape of aggregation is more rugged than the
evolved folding landscape of globular proteins.
Specifically, we have found that the FPhys fibrils
formed by lysozyme, which are intrinsically less
stable than the FAcid fibrils, remain in essentially the
same conformational state when the pH is changed
to that in which the FAcid fibrils form (Figs. 4 and 5).
This finding provides clear evidence for the presence
of at least two local minima on the energy landscape
separated by a kinetic barrier sufficiently high to
prevent the interconversion of these two species
in vitro. This lack of ability of the aggregation
process, under physiological pH, to achieve the
most stable form of amyloid fibrils is similar to that
observed in the yeast prion protein Sup3537 and in
the polyQ protein huntingtin, where aggregation
reactions carried out at 37 °C led to amyloid fibrils
that had a higher thermal stability than those
formed at 4 °C, presumably because the kinetic
barrier that led to the most stable fibrillar mor-
phology was too high to be overcome at the lower
temperature.43 While amyloid polymorphism in
the aggregation of intrinsically disordered proteins
and peptides19,41 is often found to have a thermo-
dynamic origin, our results with lysozyme show
that it can also have a kinetic origin and be a direct
consequence of the ruggedness of the energy
landscape of the aggregating protein caused, at
least in part, by the presence of four disulfide
bridges that remain formed in the amyloid fibrils.
The study of polymorphism in protein aggregates
is evidently important for our understanding of the
physical principles that govern fibril formation but
is also very timely due to recent suggestions that theibrils measured at pH 7.5 (a) and pH 2.0 (b). The ANS
tion of the ANS concentration. Protein concentration was
d FAcid (orange) fibrils isolated after 1 h reduction of the
ts was 100 μM. (c and d, insets) Time dependence of the
ion with TCEP. (e and f) TEM images of the FPhys and FAcid
792 Lysozyme Aggregates and Cytoxicitydegree of cross-β structure present in non-fibrillar
oligomers is related to their cytotoxicity and,
potentially, to their ability to trigger neurodegener-
ative disorders. 44 This structure–activity
relationship5,45 is, however, very difficult to verify
at equilibrium due to the transient nature of the
metastable species populated during fibril
formation.7,46,47 Establishing structure–activity rela-
tionships in amyloid structures is also important
because the phenotypic traits associated with prion
diseases are due to the existence of different amyloid
morphologies, formed by the same sequence and
presenting different physical and structural proper-
ties, the so-called prion strains.14 The availability of
kinetically stable amyloid morphologies of lyso-
zyme with different degrees of cross-β structure,
which can be formed under controlled and repro-
ducible conditions, has given us a unique opportu-
nity to determine whether the presence of large non-
core regions in the fibrillar material is related to
cytotoxicity. The results that we have obtained show
that FPhys fibrils, which are less ordered in the cross-β
structure, generate a significant cytotoxic effect while
the highly organized FAcid fibrils have a small or
negligible effect on cell viability. These findings
suggest that even aggregates with all the hallmarks
of amyloid fibrils, but provided with extensive non-
core regions, can give rise to cytotoxicity; they,
therefore, support the hypothesis that the cytotoxi-
city of certain protein aggregates is related to their
structural and dynamic properties and, in particular,
to the presence of substantial non-core regions.
It is possible to invoke a number of mechanisms
by which the presence of non-core regions in
amyloid fibrils could give rise to cytotoxicity. The
most straightforward of them would involve inter-
actions of the non-core regions of the fibrils with the
cell membrane, in the extracellular environment or,
inside the cell, with components of the cellular
machinery.7,9,10 It is however possible that other
phenomena play a role in triggering cytotoxicity
because the size of the cross-β core defines
important mechanical properties of amyloid fibrils
such as their propensity to fragment.6,48–51 Our
observation that the size distributions of both
fibrillar morphologies are similar suggests that
interactions between fibrils and cells could underlie
cytotoxicity, but further experiments will be re-
quired to determine the mechanism by which FPhys
fibrils decrease cell viability.Conclusion
Understanding why protein deposition leads to
disease will be crucial in developing therapeutic
approaches aimed at preventing or curing increas-
ingly prevalent disorders such as Alzheimer's and
Parkinson's diseases. The results that we obtainedwith human lysozyme clearly indicate that the
presence of kinetic traps in the energy landscape of
the aggregated protein can lead to the formation of
species that are only partially structured in the cross-β
conformation. That these fibrillar species lead to
cytotoxicity strongly suggests that this phenomenon
is associated with the presence of regions of the
polypeptide chain that are not structured in the
cross-β conformation either directly or as a result of
their effect on fibril stability.
Materials and Methods
Materials
Human lysozyme was expressed and purified as
previously described.52 ANS and thioflavin-T (ThT) were
purchased from Sigma-Aldrich (St. Louis, MO). All other
chemicals were of analytical reagent grade and were
obtained from Sigma-Aldrich.
Methods
Formation of human lysozyme amyloid fibrils at pH 2.0
and pH 7.5
Fibrils were prepared at pH 7.5 by dissolving lysozyme
in 50 mM Na2HPO4 at a concentration of 0.7 mM and
stirring the solution at 60 °C for 1 day. Formation of fibrils
at pH 2.0 was induced by seeding a 1 mM lysozyme
solution in 10mMHCl, pH 2.0, at a ratio of 2% (w/w)with
aliquots of fibrils preformed at pH 2.0, 50 °C, in the
absence of seeding. The suspension was then left at 50 °C
and stirred for up to 6 days. Samples of fibrils, isolated by
ultracentrifugation (90,000 rpm, 4 °C, 1.5 h), were
characterized by ThT binding and TEM. The insoluble
material was dissolved in 95% dimethyl sulfoxide (DMSO)
and analyzed by SDS-PAGE, reverse-phase high-perfor-
mance liquid chromatography, and mass spectrometry.
Optical spectroscopy
Protein concentrations were evaluated from absorption
measurements at 280 nm on a single-beam Cary 400 Scan
spectrophotometer (Varian, Palo Alto, CA, USA). The
extinction coefficient of full-length human lysozyme53 at
280 nm was 36,940 cm−1 M−1 .
Fluorescence measurements were carried out on a Varian
model Cary Eclipse spectrofluorimeter in a temperature-
controlled cell holder, utilizing a 2 mm×10 mm path-length
cuvette. For each measurement, a protein concentration of
2.4μMwasused. ThTbindingwasmonitoredby exciting the
sample at 440 nm and recording the emission fluorescence
spectrum from450 to 600nm. For eachmeasurement, 25μl of
a 2.5 mM ThT stock solution prepared in 10 mM phosphate
buffer (pH 7.0) containing 150 mM NaCl was added to a
volume of fibrils corresponding to 60 μg and a volume of
1.5 ml was reached with the phosphate buffer. The
fluorescence emission of ThT at 485 nm was fitted to a
four-parameter sigmoidal curve using Sigma Plot (Systat
Software Inc., California,USA) for each aggregation reaction.
For ANS titration, aliquots of ANS from a stock solution in
†http://www.esrf.fr/computing/scientific/FIT2D
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concentration ranging from 0 to 200 μM. The final protein
concentration was 5 μM in all cases. The spectra were
immediately acquired at 20 °C, using an excitation wave-
length of 350 nm and an emission range from 380 to 700 nm.
The difference between the resulting fluorescence intensity at
470 nm and that measured with only ANS in the absence of
protein was used as the effective bound ANS fluorescence.
The extinction coefficient at 350 nm of ANS was
4950 cm−1 M−1.35 Each assay was repeated three times.
Reduction of fibrillar disulfide bonds
To follow the reaction of lysozyme fibrils with the
reducing agent TCEP, we resuspended amyloid fibrils
isolated by ultracentrifugation in 10 mM HCl, pH 2.0,
containing 10 molar excess of TCEP over the number of
cysteines in the sample at 25 °C. From the reaction tube,
100 μl was taken at given time points (1–3 h) and
ultracentrifuged (90,000 rpm, 4 °C, 45 min), and the
resulting pellet was washed and resuspended in 10 mM
HCl, pH 2.0. Aliquots of these samples were taken for the
5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB) assay, ANS
titration, and TEM. Working at acidic pH allowed the
disulfide bonds to be reduced with TCEP54 while
maintaining the fibrillar morphologies as well as the
oxidation state of the cysteine side chains. Free thiol
groups in fibrillar samples were determined spectropho-
tometrically at 412 nm using the DTNB assay.55 Fibrillar
samples (7 μM) were incubated for 15 min at 25 °C with
0.17 mM DTNB in 0.1 M potassium phosphate buffer and
1 mM ethylenediaminetetraacetic acid (EDTA), pH 8.0.
The values of absorbance at 412 nmwere compared with a
calibration curve obtained with known amounts of fully
reduced lysozyme. Each assay was repeated three times.
Cellular viability monitored by the MTT assay
The cytotoxicity of fibrils was determined using theMTT
assay. Neuroblastoma SH-SY5Y cells were cultured in
Dulbecco's modified Eagle's medium supplemented with
10% (v/v) fetal bovine serum, 1% glutamine, and
antibiotics in a 5% CO2 humidified atmosphere at 37 °C.
They were plated (2000 cells/well) in a 96-well plate and
incubated for 24 h. The incubation medium was then
removed, and preparations of protein diluted in Dulbecco's
modified Eagle's medium were added at concentrations
between 10 and 75 μMand incubated for 48 h at 37 °C. After
46 h, MTT was added to a final concentration of 0.5 mg/ml
and the cells were incubated for two additional hours. The
medium was then removed, and 200 μl of 2-propanol was
added in order to dissolve the purple formazan produced.
The absorbance was then measured at 570 nm after 45 min
and cell viability percentages were determined by dividing
the absorbance value of cells treated with protein by that of
untreated cells.
SDS-PAGE analysis
Fibrillar samples, previously dissolved in DMSO, were
analyzed by SDS-PAGEusing 4–12% 2-[bis(2-hydroxyethyl)
amino]-2-(hydroxymethyl)propane-1,3-diol NuPAGE gels
(Invitrogen UK) in 4-morpholineethanesulfonic acid buffer
under reducing conditions. Gels were stained using
Coomassie brilliant blue.Bradford assay
Protein solutions (20 μl) were diluted 1:25 into the
Bradford solution (Sigma-Aldrich) and left for 30 min at
25 °C, and the measured absorbance at 595 nm was
compared with a calibration curve previously established
using standard lysozyme solutions.
Transmission electron microscopy
Samples were applied to Formvar-coated nickel grids,
stained with 2% (w/v) uranyl acetate solution, and
viewed in a Phillips CEM100 transmission electron
microscope operating at 80 kV. TEM images were
analyzed using the ImageJ software.
X-ray fiber diffraction
Amyloid fibril samples were prepared for X-ray
diffraction analysis using a modification of the stretch-
frame method.56 In this modification, the distance
between capillary tubes is not changed during the
production of the semi-aligned, dry stalk. A 10-μl droplet
of fibril suspension was placed between two horizontal
wax-plugged glass capillary tubes of 1 mm diameter held
approximately 2 mm apart. Upon drying of the droplet to
approximately a quarter of its initial volume, a further 5 μl
of fibril suspension was added and the process was
repeated a further three times. Subsequently, the droplet
was left to dry completely in air. All scattering patterns
were obtained on a crystallography beamline at the
Department of Biochemistry of the University of Cam-
bridge. X-rays with a wavelength of 1.54 Å were produced
by a rotating copper anode and collimated and focused by
Osmic Max-flux optics, and images were acquired on a
Marr image plate. The sample–detector distance was
300 mm, and data acquisition times were typically 15 min.
Images were analyzed and radially integrated to generate
1D scattering patterns using Fit2D† to obtain accurate
reflection positions.
pH change of fibrillar samples
The pH of fibril samples was adjusted to the desired
value by adding minimal volumes (1–4% v/v) of concen-
trated HCl and NaOH solutions. The final pH value was
measuredwith a pHmeter.After 24 h at room temperature,
the pH-swapped fibril samples were analyzed by using
ultracentrifugation (90,000 rpm, 90 min, 4 °C), TEM, IR
spectroscopy, and depolymerization experiments.
Attenuated total reflectance Fourier transform infrared
spectroscopy
For secondary-structure analysis of fibrils, samples were
analyzed in a Bruker BioATRCell II using a Bruker
Equinox 55 FTIR spectroscopy spectrometer (BrukerOptics
Limited, UK) equipped with a liquid-nitrogen-cooled
mercury cadmium telluride detector and a silicon internal
reflection element. For each spectrum, 256 interferograms
were coadded at 2 cm–1 resolution, and the buffer
background was independently measured and subtracted
794 Lysozyme Aggregates and Cytoxicityfrom each protein spectrum, before curve fitting of the
amide I region (1720–1580 cm−1 ). Calculation of the second
derivatives was used to identify peak maxima. Using this
information, we then fitted the raw spectra to a series of
Gaussian peaks with the identified absorbance maxima
using an iterative curve-fitting procedure performed in
Origin8 (OriginLab Corporation, Massachusetts, USA).
Measurement of conformational stability of fibrils
To measure the stability of fibrillar lysozyme, we
diluted aliquots of fibrils into buffered solutions contain-
ing increasing concentrations of GdnHCl or GdnSCN, and
after 72 h at 25 °C, the samples were ultracentrifuged
(90,000 rpm, 20 °C, 45 min). The concentration of
lysozyme in the supernatant was measured by recording
the absorbance at 280 nm or by using the Bradford assay.
The depolymerization curves were obtained by plotting
the fraction of lysozyme released from the fibrils at
various concentrations of denaturant. The time depen-
dence of fibril depolymerization was studied by following
the amount of lysozyme released by fibrils after dilution
into a given concentration of chaotropic agent, in a time
period from 15 min to 6 days. Samples of fibrils were
diluted into buffered solution containing high concentra-
tion of GdnHCl or GdnSCN: at given time points, aliquots
of these samples were ultracentrifuged and the concen-
tration of protein in the supernatant was measured. The
results showed that after a very fast initial release (2 h), the
system reached equilibrium (Fig. S2).Acknowledgements
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